Management of epilepsy associated with tuberous sclerosis complex (TSC): Clinical recommendations

European Journal of Paediatric Neurology

Volumn 16, Issue 6, 2012, Pages 582-586

  Curatolo, Paolo ^a   Jóźwiak, Sergiusz ^b   Nabbout, Rima ^c  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b CHILDREN'S MEMORIAL HEALTH INSTITUTE   (Poland)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Clinical recommendations; Consensus; Epilepsy; mTOR; Tuberous sclerosis complex (TSC)

Indexed keywords

EVEROLIMUS; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; VIGABATRIN;

COGNITION; ELECTROENCEPHALOGRAPHY; EPILEPSY; HUMAN; INFANTILE SPASM; KETOGENIC DIET; NONHUMAN; PARENT COUNSELING; PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PRENATAL DIAGNOSIS; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; RISK ASSESSMENT; TREATMENT PLANNING; TUBEROUS SCLEROSIS; VAGUS NERVE STIMULATION; VISUAL FIELD;

ANTICONVULSANTS; CHILD; CHILD, PRESCHOOL; CONSENSUS; EPILEPSY; GUIDELINES AS TOPIC; HUMANS; INFANT; INFANT, NEWBORN; KETOGENIC DIET; NEUROSURGICAL PROCEDURES; TOR SERINE-THREONINE KINASES; TUBEROUS SCLEROSIS; VAGUS NERVE STIMULATION;

EID: 84867101893     PISSN: 10903798     EISSN: 15322130     Source Type: Journal    
DOI: 10.1016/j.ejpn.2012.05.004     Document Type: Review

References (28)

1. J. Jozwiak Possible mechanisms of disease development in tuberous sclerosis Lancet Oncol 9 2008 73 79
2. P. Curatolo Tuberous sclerosis Lancet 372 9639 2008 657 668
3. M. Wong Mammalian target of rapamycin (mTOR) inhibition as a potential antiepileptogenic therapy: from tuberous sclerosis to common acquired epilepsies Epilepsia 51 2010 27 36
4. V. Napolioni Recent advances in neurobiology of tuberous sclerosis complex Brain Dev 31 2009 104 113
5. C.J. Chu-Shore The natural history of epilepsy in tuberous sclerosis complex Epilepsia 51 2010 1236 1241
6. R. Cusmai Topographic comparative study of magnetic resonance imaging and electroencephalography in 34 children with tuberous sclerosis Epilepsia 31 1990 747 755
7. F.J. O'Callaghan The relation of infantile spasms, tubers, and intelligence in tuberous sclerosis complex Arch Dis Child 89 2004 530 533
8. F.E. Jansen Overlapping neurologic and cognitive phenotypes in patients with TSC1 or TSC2 mutations Neurology 70 2008 908 915
9. D.A. Krueger Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis N Engl J Med 363 2010 1801 1811
10. R. Moavero Epilepsy secondary to tuberous sclerosis: lessons learned and current challenges Childs Nerv Syst 26 2010 1495 1504
11. E. Hancock, and J.P. Osborne Vigabatrin in the treatment of infantile spasms in tuberous sclerosis: literature review J Child Neurol 14 1999 71 74
12. L.H. Zeng Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex Ann Neurol 63 2008 444 453
13. M.C. Ljungberg Rapamycin suppresses seizures and neuronal hypertrophy in a mouse model of cortical dysplasia Dis Model Mech 2 2009 389 398
14. D. Ehninger Reversal of learning deficits in a Tsc2+/- mouse model of tuberous sclerosis Nat Med 14 2008 843 848
15. M.M. Guerreiro Surgical treatment of epilepsy in tuberous sclerosis: strategies and results in 18 patients Neurology 51 1998 1263 1269
16. J.Y. Wu Noninvasive testing, early surgery, and seizure freedom in tuberous sclerosis complex Neurology 74 2010 392 398
17. F.E. Jansen Epilepsy surgery in tuberous sclerosis: a systematic review Epilepsia 48 2007 1477 1484
18. P. Major, and E.A. Thiele Vagus nerve stimulation for intractable epilepsy in tuberous sclerosis complex Epilepsy Behav 13 2008 357 360
19. R.E. Elliott Refractory epilepsy in tuberous sclerosis: vagus nerve stimulation with or without subsequent resective surgery Epilepsy Behav 16 2009 454 460
20. E.H. Kossoff Tuberous sclerosis complex and the ketogenic diet Epilepsia 46 2005 1684 1686
21. J.R. Yates Tuberous sclerosis Eur J Hum Genet 14 2006 1065 1073
22. S. Jóźwiak Antiepileptic treatment before the onset of seizures reduces epilepsy severity and risk of mental retardation in infants with tuberous sclerosis complex Eur J Paediatr Neurol 15 2011 424 431
23. R. Bombardieri Early control of seizures improves long-term outcome in children with tuberous sclerosis complex Eur J Paediatr Neurol 14 2010 146 149
24. M. Bialer Progress report on new antiepileptic drugs: a summary of the Seventh Eilat Conference (EILAT VII) Epilepsy Res 61 2004 1 48
25. F.J. Ascaso Visual field defects in pediatric patients on vigabatrin monotherapy Doc Ophthalmol 107 2003 127 130
26. D.M. Talos The interaction between early life epilepsy and autistic-like behavioral consequences: a role for the Mammalian Target of Rapamycin (mTOR) pathway PLoS One 7 2012 e35885
27. J. Muncy Rapamycin reduces seizure frequency in tuberous sclerosis complex J Child Neurol 24 2009 477
28. M. Perek-Polnik Effective everolimus treatment of inoperable, life-threatening subependymal giant cell astrocytoma and intractable epilepsy in a patient with tuberous sclerosis complex Eur J Paediatr Neurol 16 2012 83 85